Leuprolide Acetate Market By Mode of Administration ( Intramuscular, Subcutaneous ), By Application ( Prostate Cancer, Uterine Fibroid ), By End-use ( Hospitals, Clinics, Medical Institutes ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 178
Leuprolide Acetate Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Leuprolide acetate is a nonapeptide acetate salt which can be used as a substitute to the gonadotropin-releasing hormone. The leuprolide acetate hormone analogue is used for curing or inhibiting certain diseases prevalent in both men and women. Leupron is the brand name by which leuprolide acetate injections are commercialized throughout the world. The salt has been found highly efficient for certain therapies used for prohibiting the growth of prostate cancer in men. Prostate cancer is highly stimulated by the generation of testosterones in the body. Leupron acts as a LHRH agonist. LHRH is a naturally occurring hormone that stimulates the production of testosterone in the testes. The introduction of Lupron effectively blocks LHRH, and hence, it reduces the amount of testosterone in the body. Lupron has been proven highly efficient in lowering the androgen levels or stopping them from getting into prostate cancer cells. This makes prostate cancers either to shrink or to grow very slowly. As per NIH, in 2015, there were an estimated 3,120,176 men living with prostate cancer in the United States. Lupron is also prescribed for the women dealing with endometriosis and Uterine Fibroids, which are one of the most complicated and painful diseases related to female reproductive system. As per a survey by nearly 10% of the total women worldwide are suffering with endometriosis. Such a scenario might act as a major stimulating factor for the demand of Lupron. However, generation of side effects such as redness, burning, tiredness and nausea might create a reluctance among the patients to opt this treatment. Apart from this the availability of better substitutes such as Firmagon, might act as a restraining factor for the market growth. The report provides detailed qualitative and quantitative analysis of the Global Leuprolide Acetate Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Leuprolide Acetate Market Segmentation

By Mode of Administration • Intramuscular • Subcutaneous By Application • Prostate Cancer • Uterine Fibroid • Others By End-Use • Hospitals • Clinics • Medical Institutes • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. LEUPROLIDE ACETATE MARKET OVERVIEW 2.1. LEUPROLIDE ACETATE MARKET INTRODUCTION 2.2. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Leuprolide Acetate Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL LEUPROLIDE ACETATE MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Leuprolide Acetate Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Leuprolide Acetate Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL LEUPROLIDE ACETATE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Leuprolide Acetate Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL LEUPROLIDE ACETATE MARKET PRICE TREND, 2017-2025 2.6.1. Global Leuprolide Acetate Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL LEUPROLIDE ACETATE MARKET BY MODE OF ADMINISTRATION, 2017-2025 3.1. INTRAMUSCULAR 3.2. SUBCUTANEOUS 3.3. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY MODE OF ADMINISTRATION, 2017-2025 3.3.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Mode of Administration, 2017-2025 3.3.2. Intramuscular Market Revenue and Growth Rate, 2017-2025 3.3.3. Subcutaneous Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION BY MODE OF ADMINISTRATION, 2017-2025 3.4.1. Global Leuprolide Acetate Market Production (Volume) and Share (%) By Mode of Administration, 2017-2025 3.4.2. Intramuscular Market Production and Growth Rate, 2017-2025 3.4.3. Subcutaneous Market Production and Growth Rate, 2017-2025 CHAPTER 4. GLOBAL LEUPROLIDE ACETATE MARKET BY APPLICATION, 2017-2025 4.1. PROSTATE CANCER 4.2. UTERINE FIBROID 4.3. OTHERS 4.4. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY APPLICATION, 2017-2025 4.4.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.4.2. Prostate Cancer Market Revenue and Growth Rate, 2017-2025 4.4.3. Uterine Fibroid Market Revenue and Growth Rate, 2017-2025 4.4.4. Others Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL LEUPROLIDE ACETATE MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.5.1. Global Leuprolide Acetate Market Consumption (Volume) and share (%) By Application, 2017-2025 4.5.2. Prostate Cancer Market Consumption and Growth Rate, 2017-2025 4.5.3. Uterine Fibroid Market Consumption and Growth Rate, 2017-2025 4.5.4. Others Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for end user segment. CHAPTER 5. GLOBAL LEUPROLIDE ACETATE MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Leuprolide Acetate Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Leuprolide Acetate Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL LEUPROLIDE ACETATE MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL LEUPROLIDE ACETATE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Leuprolide Acetate Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL LEUPROLIDE ACETATE REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 36 8.2.1. Global Leuprolide Acetate Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. LEUPROLIDE ACETATE MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Leuprolide Acetate Market Share (%) of Top 3 Manufacturers 8.3.2. Leuprolide Acetate Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL LEUPROLIDE ACETATE MANUFACTURERS ANALYSIS 9.1. SUN PHARMACEUTICAL INDUSTRIES LTD. 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Leuprolide Acetate Product Details 9.1.4. Sun Pharmaceutical Industries Ltd. Leuprolide Acetate Production, Revenue and Gross Margin 9.2. VARIAN PHARMED 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Leuprolide Acetate Product Details 9.2.4. Varian Pharmed Leuprolide Acetate Production, Revenue and Gross Margin 9.3. AVENIT AG 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Leuprolide Acetate Product Details 9.3.4. Avenit AG Leuprolide Acetate Production, Revenue and Gross Margin 9.4. TAKEDA PHARMACEUTICAL COMPANY LIMITED 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Leuprolide Acetate Product Details 9.4.4. Takeda Pharmaceutical Company Limited Leuprolide Acetate Production, Revenue and Gross Margin 9.5. LIVZON PHARMACEUTICAL GROUP CO., LTD. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Leuprolide Acetate Product Details 9.5.4. Livzon Pharmaceutical Group Co., Ltd. Leuprolide Acetate Production, Revenue and Gross Margin 9.6. BEIJING BIOTE PHARMACEUTICAL CO., LTD 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Leuprolide Acetate Product Details 9.6.4. Beijing Biote Pharmaceutical Co., Ltd Leuprolide Acetate Production, Revenue and Gross Margin 9.7. SOHO-YIMING 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Leuprolide Acetate Product Details 9.7.4. Soho-YImIng Leuprolide Acetate Production, Revenue and Gross Margin 9.8. ABBVIE INC. 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Leuprolide Acetate Product Details 9.8.4. AbbVie Inc. Leuprolide Acetate Production, Revenue and Gross Margin 9.9. SANOFI 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Leuprolide Acetate Product Details 9.9.4. Sanofi Leuprolide Acetate Production, Revenue and Gross Margin 9.10. ASTELLAS PHARMA 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Leuprolide Acetate Product Details 9.10.4. Astellas Pharma Leuprolide Acetate Production, Revenue and Gross Margin CHAPTER 10. LEUPROLIDE ACETATE MARKET VALUE CHAIN ANALYSIS 10.1. LEUPROLIDE ACETATE INDUSTRIAL CHAIN ANALYSIS 10.2. LEUPROLIDE ACETATE KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Sun Pharmaceutical Industries Ltd.
• Varian Pharmed
• Avenit AG
• Takeda Pharmaceutical Company Limited
• Livzon Pharmaceutical Group Co., Ltd.
• Beijing Biote Pharmaceutical Co., Ltd
• Soho-YImIng
• AbbVie Inc.
• Sanofi
• Astellas Pharma
• Abbott
• Merck KGaA
• Pfizer Inc.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS